tiprankstipranks
VistaGen Therapeutics (VTGN)
NASDAQ:VTGN
US Market
Holding VTGN?
Track your performance easily

VistaGen Therapeutics (VTGN) Financial Statements

755 Followers

VistaGen Therapeutics Financial Overview

VistaGen Therapeutics's market cap is currently ―. The company's EPS TTM is $-2.16; its P/E ratio is -1.81; VistaGen Therapeutics is scheduled to report earnings on August 8, 2024, and the estimated EPS forecast is $-0.40. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue$ 197.30K$ 411.40K$ 277.70K--
Gross Profit$ 374.90K$ 411.40K$ 277.70K--
EBIT$ -11.36M$ -7.88M$ -6.78M$ -7.00M-
EBITDA$ -11.21M$ -7.74M-$ -6.86M-
Net Income Common Stockholders$ -9.52M$ -6.35M$ -6.59M$ -6.90M-
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 119.20M$ 126.56M$ 37.61M$ 9.62M$ 16.64M
Total Assets$ 123.69M$ 131.07M$ 42.20M$ 15.03M$ 21.09M
Total Debt$ 2.12M$ 2.25M$ 2.38M$ 2.50M$ 2.61M
Net Debt$ -117.08M$ -124.30M$ -35.23M$ -7.12M$ -14.02M
Total Liabilities$ 9.37M$ 7.78M$ 6.55M$ 8.18M$ 8.90M
Stockholders Equity$ 114.30M$ 123.28M$ 35.65M$ 6.85M$ 12.08M
Cash Flow-
Free Cash Flow$ -7.20M$ -4.54M-$ -7.89M-
Operating Cash Flow$ -7.20M$ -4.54M$ -6.19M$ -7.89M-
Investing Cash Flow$ -28.70K$ -32.30K---
Financing Cash Flow$ -167.80K$ 93.52M$ 34.18M$ 875.60K-
Currency in USD

VistaGen Therapeutics Earnings and Revenue History

VistaGen Therapeutics Debt to Assets

VistaGen Therapeutics Cash Flow

VistaGen Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis